z-logo
open-access-imgOpen Access
A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8 + T cell-mediated anti-tumor immunity
Author(s) -
R. Watkins-Schulz,
P. Tiet,
M.D. Gallovic,
R.D. Junkins,
Cécile Batty,
E.M. Bachelder,
K.M. Ainslie,
J.P.Y. Ting
Publication year - 2019
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/rcfh-4z30
Subject(s) - immunotherapy , cd8 , sting , immunology , immunity , natural killer cell , cytotoxic t cell , cancer research , medicine , biology , immune system , engineering , in vitro , biochemistry , aerospace engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom